Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis.

ABSTRACT:

SUBMITTER: Venugopal N 

PROVIDER: S-EPMC12764680 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature